Oncology Research Review, Issue 41

In this issue:

Prognostic and predictive factors in oesophagogastric cancer
Low uptake of the English Bowel CRC Screening Programme
Ramucirumab + FOLFIRI: biomarkers do not affect response
Consensus Molecular Subtypes and mCRC data
DT intervention improves survival in mCRC to liver or lung
First-line TKI + LCT for EGFR-mutant NSCLC
Post-cancer illness perceptions matter for survival
Significant under-reporting and delayed publication of QOL data
Nivolumab ± ipilimumab in metastatic gastro-oesophageal cancer
Avelumab vs chemotherapy in advanced gastro-oesophageal cancer

Please login below to download this issue (PDF)

Subscribe